Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in comparison to one containing levonorgestrel and ethinylestradiol on markers of endocrine function

REFERENCES

• United Nations Department of Economic and Social Affairs Population Division. World contraceptive use 2007. Accessed 5 August 2009 from: http://www.un.org/esa/population/publications/contraceptive2007/contraceptive_2007_table.pdf
   Google Scholar
• Farley TM, Collins J, Schlesselman JJ. Hormonal contraception and risk of cardiovascular disease. An international perspective. Contraception 1998;57:211–30.
   PubMed Web of Science ®Google Scholar
• Sitruk-Ware R, Nath A. The use of newer progestins for contraception. Contraception 2010;82:410–7.
   PubMed Web of Science ®Google Scholar
• Ahrendt HJ, Makalova D, Parke S, . Bleeding pattern and cycle control with an estradiol-based oral contraceptive: A seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel. Contraception 2009;80:436–44.
   PubMed Web of Science ®Google Scholar
• Palacios S, Wildt L, Parke S, . Efficacy and safety of a novel oral contraceptive based on oestradiol (oestradiol valerate/dienogest): A phase III trial. Eur J Obstet Gynecol Reprod Biol 2010;149:57–62.
   PubMed Web of Science ®Google Scholar
• Astedt B, Jeppsson S, Liedholm P, . Clinical trial of a new oral contraceptive pill containing the natural oestrogen 17beta-oestradiol. Br J Obstet Gynaecol 1979; 86:732–6.
   PubMedGoogle Scholar
• Serup J, Bostofte E, Larsen S, Westergaard J. Effectivity and acceptability of oral contraceptives containing natural and artificial estrogens in combination with a gestagen. A controlled double-blind investigation. Acta Obstet Gynecol Scand 1981;60:203–6.
   PubMed Web of Science ®Google Scholar
• Wenzl R, Bennink HC, van Beek A, . Ovulation inhibition with a combined oral contraceptive containing 1 mg micronized 17beta-estradiol. Fertil Steril 1993;60:616–9.
   PubMed Web of Science ®Google Scholar
• Csemiczky G, Dieben T, Coeling Bennink HJ, Landgren BM. The pharmacodynamic effects of an oral contraceptive containing 3 mg micronized 17[beta]-estradiol and 0.150 mg desogestrel for 21 days, followed by 0.030 mg desogestrel only for 7 days. Contraception 1996;54:333–38.
   PubMed Web of Science ®Google Scholar
• Calafi Alsina JC. After 50 years of ethinylestradiol, another oestrogen in combined oral contraceptives. Eur J Contracept Reprod Health Care 2010;15:1–3.
   PubMed Web of Science ®Google Scholar
• Lello S. Nomegestrol acetate: Pharmacology, safety profile and therapeutic efficacy. Drugs 2010;70:541–59.
   PubMed Web of Science ®Google Scholar
• Duijkers IJ, Klipping C, Grob P, Korver T. Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17beta-oestradiol on ovarian function in comparison to a monophasic combined oral contraceptive containing drospirenone and ethinylestradiol. Eur J Contracept Reprod Health Care 2010;15:314–25.
   PubMed Web of Science ®Google Scholar
• van der Vange N, Blankenstein MA, Kloosterboer HJ, . Effects of seven low-dose combined oral contraceptives on sex hormone binding globulin, corticosteroid binding globulin, total and free testosterone. Contraception 1990;41:345–52.
   PubMed Web of Science ®Google Scholar
• Wiegratz I, Kutschera E, Lee JH, . Effect of four oral contraceptives on thyroid hormones, adrenal and blood pressure parameters. Contraception 2003;67:361–6.
   PubMed Web of Science ®Google Scholar
• Wiegratz I, Kutschera E, Lee JH, . Effect of four different oral contraceptives on various sex hormones and serum-binding globulins. Contraception 2003;67:25–32.
   PubMed Web of Science ®Google Scholar
• Ågren UM, Anttila M, Mäenpää-Liukko K, . Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17beta-oestradiol on haemostasis, lipids and carbohydrate metabolism. Eur J Contracept Reprod Health Care 2011;16:444–57.
   PubMed Web of Science ®Google Scholar
• World Health Organization Medical eligibility criteria for contraceptive use, 4th. Geneva: WHO Press 2009: 1–121. Accessed 22 June 2011 from: http://whqlibdoc.who.int/publications/2010/9789241563888_eng.pdf
   Google Scholar
• Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999;84:3666–72.
   PubMed Web of Science ®Google Scholar
• Lehmann EL. Nonparametrics: Statistical methods based on ranks. Oakland, CA: Holden-Day, Inc. 1975:81–95.
   Google Scholar
• Hammond GL, Langley MS, Robinson PA, . Serum steroid binding protein concentrations, distribution of progestogens, and bioavailability of testosterone during treatment with contraceptives containing desogestrel or levonorgestrel. Fertil Steril 1984;42:44–51.
   PubMed Web of Science ®Google Scholar
• Humpel M, Tuber U, Kuhnz W, . Comparison of serum ethinyl estradiol, sex hormone-binding globulin, corticoid-binding globulin and cortisol levels in women using two low-dose combined oral contraceptives. Horm Res 1990;33:35–9.
   PubMed Web of Science ®Google Scholar
• Zeun S, Lu M, Uddin A, . Pharmacokinetics of an oral contraceptive containing oestradiol valerate and dienogest. Eur J Contracept Reprod Health Care 2009;14:221–32.
   PubMed Web of Science ®Google Scholar
• Wiegratz I, Jung-Hoffmann C, Kuhl H. Effect of two oral contraceptives containing ethinylestradiol and gestodene or norgestimate upon androgen parameters and serum binding proteins. Contraception 1995;51:341–6.
   PubMed Web of Science ®Google Scholar
• Duijkers I, Killick S, Bigrigg A, Dieben TO. A comparative study on the effects of a contraceptive vaginal ring NuvaRing and an oral contraceptive on carbohydrate metabolism and adrenal and thyroid function. Eur J Contracept Reprod Health Care 2004;9:131–40.
   PubMed Web of Science ®Google Scholar
• Kuhl H, Gahn G, Romberg G, . A randomized cross-over comparison of two low-dose oral contraceptives upon hormonal and metabolic serum parameters: II. Effects upon thyroid function, gastrin, STH, and glucose tolerance. Contraception 1985;32:97–107.
   PubMed Web of Science ®Google Scholar
• Sanger N, Stahlberg S, Manthey T, . Effects of an oral contraceptive containing 30 mcg ethinyl estradiol and 2 mg dienogest on thyroid hormones and androgen parameters: Conventional vs. extended-cycle use. Contraception 2008;77:420–5.
   PubMed Web of Science ®Google Scholar
• Rich P. Hormonal contraceptives for acne management. Cutis 2008;81:13–8.
   PubMed Web of Science ®Google Scholar
• Davison SL, Bell RJ, LaChina M, . Sexual function in well women: Stratification by sexual satisfaction, hormone use, and menopause status. J Sex Med 2008;5:1214–22.
   PubMed Web of Science ®Google Scholar
• Wierman ME, Nappi RE, Avis N, . Endocrine aspects of women's sexual function. J Sex Med 2010;7:561–85.
   PubMed Web of Science ®Google Scholar